微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 8.78% | -13.07% | 56.23% | 30/159 | 3.55% | 翰宇药业 | 52.19% | 行业排名> |
| 2026-06-30 | 5.62% | -9.94% | 103.62% | 29/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 2.76% | -0.36% | -77.87% | 35/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 12.47% | 10.26% | 23.47% | 17/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 10.1% | -0.1% | 61.86% | 25/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 6.24% | 5.76% | 125.27% | 25/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 2.77% | -9.48% | -75.51% | 36/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 11.31% | 12.65% | 11.87% | 24/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 10.11% | 12.71% | 71.36% | 26/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.9% | 6.88% | 92.81% | 30/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.06% | 5.52% | -69.52% | 30/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.04% | -18.04% | 11.93% | 32/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.97% | -5.38% | 62.5% | 30/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.52% | -2.13% | 90.34% | 33/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.9% | 1.75% | -76.33% | 36/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 12.25% | 1.58% | 29.22% | 28/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 9.48% | -10.73% | 68.09% | 33/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.64% | -0.53% | 97.89% | 39/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.85% | -14.67% | -76.37% | 42/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 12.06% | 1.52% | 13.56% | 33/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 10.62% | -3.37% | 87.3% | 28/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.67% | 5.19% | 69.76% | 45/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.34% | 27% | -71.89% | 34/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 11.88% | 1.89% | 8.1% | 42/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 10.99% | -18.71% | 103.9% | 33/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.39% | -21.31% | 104.94% | 48/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 2.63% | -28.34% | -77.44% | 38/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.66% | 39.47% | -13.76% | 44/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 13.52% | 51.23% | 97.37% | 15/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.85% | 37.27% | 86.65% | 30/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.67% | 65.32% | -56.1% | 24/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 8.36% | 476.55% | -6.49% | 60/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.94% | -6.49% | 79.16% | 31/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.99% | -20.03% | 124.77% | 40/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.22% | -27.21% | 53.1% | 47/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 1.45% | -82.68% | -84.83% | 109/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.56% | 9.51% | 53.21% | 33/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 6.24% | 11.43% | 104.59% | 31/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.05% | 13.38% | -63.56% | 25/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 8.37% | -14.33% | -4.12% | 64/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 8.73% | -11.55% | 55.89% | 31/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 5.6% | -9.82% | 108.18% | 38/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.69% | -6.92% | -72.47% | 30/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |